Cheng S-S, Jiang J-G, Lin S-C, Yu Y-H, Chang TW, Lim C, Yu Y-B, Chu H-M. TE-1146, a novel anti-CD38-antibody-lenalidomide conjugate, demonstrates potent <i>ex vivo</i> anti-myeloma activity. haematol [Internet]. 2020Sep.10 [cited 2025Dec.19];. Available from: https://haematologica.org/article/view/12982